SE466447B - N-aminoetylbensamidderivat samt farmaceutiska preparat daerav - Google Patents

N-aminoetylbensamidderivat samt farmaceutiska preparat daerav

Info

Publication number
SE466447B
SE466447B SE8401190A SE8401190A SE466447B SE 466447 B SE466447 B SE 466447B SE 8401190 A SE8401190 A SE 8401190A SE 8401190 A SE8401190 A SE 8401190A SE 466447 B SE466447 B SE 466447B
Authority
SE
Sweden
Prior art keywords
benzamide
pharmaceutically usable
acid addition
aminoethyl
formula
Prior art date
Application number
SE8401190A
Other languages
English (en)
Swedish (sv)
Other versions
SE8401190L (sv
SE8401190D0 (sv
Inventor
Prada M Da
R Joos
E Kyburz
P C Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8401190D0 publication Critical patent/SE8401190D0/xx
Publication of SE8401190L publication Critical patent/SE8401190L/xx
Publication of SE466447B publication Critical patent/SE466447B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8401190A 1983-03-03 1984-03-02 N-aminoetylbensamidderivat samt farmaceutiska preparat daerav SE466447B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (de) 1983-03-03 1983-03-03 Benzamid-derivate.

Publications (3)

Publication Number Publication Date
SE8401190D0 SE8401190D0 (sv) 1984-03-02
SE8401190L SE8401190L (sv) 1984-09-04
SE466447B true SE466447B (sv) 1992-02-17

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401190A SE466447B (sv) 1983-03-03 1984-03-02 N-aminoetylbensamidderivat samt farmaceutiska preparat daerav

Country Status (28)

Country Link
JP (1) JPS59167552A (de)
KR (1) KR910008202B1 (de)
AR (1) AR243155A1 (de)
AT (1) AT390948B (de)
AU (2) AU570431B2 (de)
BE (1) BE899059A (de)
CA (1) CA1252794A (de)
CH (1) CH653670A5 (de)
DE (1) DE3407654C2 (de)
DK (1) DK166382C (de)
ES (3) ES530230A0 (de)
FI (1) FI79297C (de)
FR (1) FR2541996B1 (de)
GB (1) GB2135998B (de)
GR (1) GR81866B (de)
HU (1) HU193556B (de)
IE (1) IE57004B1 (de)
IL (1) IL71078A (de)
IT (1) IT1173365B (de)
LU (1) LU85231A1 (de)
MC (1) MC1568A1 (de)
NL (1) NL8400459A (de)
NO (1) NO165999C (de)
NZ (1) NZ207272A (de)
PH (1) PH19623A (de)
PT (1) PT78187B (de)
SE (1) SE466447B (de)
ZA (1) ZA841394B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (fr) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med Agents pour le diagnostic et le traitement des melanomes, derives halogenes aromatiques utilisables comme de tels agents et leur preparation
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (de) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (de) * 1976-04-14 1977-11-03 Basf Ag Farbstoffe der perylentetracarbonsaeurediimidreihe
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (de) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Substituierte 1-benzoyl-2-phenylimino-imidazolidine, deren saeureadditionssalze, verfahren zu deren herstellung und diese enthaltende arzneimittel
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
GB2135998B (en) 1986-09-24
DK147584D0 (da) 1984-02-29
FI79297C (fi) 1989-12-11
GR81866B (de) 1984-12-12
IT8419778A0 (it) 1984-02-23
PT78187A (en) 1984-04-01
MC1568A1 (fr) 1985-02-04
NO165999B (no) 1991-02-04
JPH0430389B2 (de) 1992-05-21
KR840009077A (ko) 1984-12-24
AU8307987A (en) 1988-06-16
AU570431B2 (en) 1988-03-17
DK166382B (da) 1993-05-10
HU193556B (en) 1987-10-28
IL71078A0 (en) 1984-05-31
FR2541996B1 (fr) 1987-12-11
AR243155A1 (es) 1993-07-30
JPS59167552A (ja) 1984-09-21
ATA72484A (de) 1990-01-15
SE8401190L (sv) 1984-09-04
FR2541996A1 (fr) 1984-09-07
NO165999C (no) 1991-05-15
AT390948B (de) 1990-07-25
GB8405486D0 (en) 1984-04-04
AU609758B2 (en) 1991-05-09
IT1173365B (it) 1987-06-24
AU2506684A (en) 1984-09-06
NO840797L (no) 1984-09-04
PH19623A (de) 1986-06-04
IL71078A (en) 1987-12-31
CA1252794A (en) 1989-04-18
FI840734A0 (fi) 1984-02-22
KR910008202B1 (ko) 1991-10-11
ES8504680A1 (es) 1985-05-01
ES537046A0 (es) 1985-08-16
LU85231A1 (de) 1985-09-12
ES8506600A1 (es) 1985-08-16
PT78187B (en) 1986-08-05
FI79297B (fi) 1989-08-31
ES537045A0 (es) 1985-08-16
DE3407654A1 (de) 1984-09-06
IE840512L (en) 1984-09-03
DK166382C (da) 1993-09-27
NZ207272A (en) 1987-07-31
CH653670A5 (de) 1986-01-15
FI840734A (fi) 1984-09-04
ZA841394B (en) 1985-06-26
ES8506601A1 (es) 1985-08-16
DE3407654C2 (de) 1994-04-07
IE57004B1 (en) 1992-03-11
NL8400459A (nl) 1984-10-01
ES530230A0 (es) 1985-05-01
GB2135998A (en) 1984-09-12
DK147584A (da) 1984-09-04
SE8401190D0 (sv) 1984-03-02
BE899059A (fr) 1984-09-03

Similar Documents

Publication Publication Date Title
US5773475A (en) Anticonvulsant enantiomeric amino acid derivatives
JP3231042B2 (ja) ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法
DK159264B (da) Analogifremgangsmaade til fremstilling af d-(threo)-1-aryl-2-acylamido-3-fluor-1-propanolforbindelser
DE3530046C2 (de) Äthylendiaminmonoamid-Derivate
SE451015B (sv) Substituerade moranolinderivat
JPH06509087A (ja) 芳香族化合物、それらを含む医薬組成物、及び治療におけるそれらの使用
EP0352581A2 (de) Aethylendiaminmonoamid-Derivate
AU715493B2 (en) Selective beta 3 adrenergic agonists
US5319096A (en) (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
SE466447B (sv) N-aminoetylbensamidderivat samt farmaceutiska preparat daerav
FR2560196A1 (fr) Nouvelles 8a-acylaminoergolines, leur preparation et leur utilisation comme medicaments
KR840000763B1 (ko) 2-아미노-3-벤조일-페닐아세트아미드의 제조방법
US5238962A (en) Benzamide derivatives
EP0275762B1 (de) Indol-Carboxamid-Derivate und ihre Salze, Verfahren und Zwischenprodukte zur Herstellung, Anwendung als Heilmittel und Zusammenstellungen, die sie enthalten
SE460419B (sv) Substituerade 1-pyridyloxi-3-indolylalkylamino-2-propanoler, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
CS228531B2 (en) Method for the production of phenylpiperazine derivates
JPH06501701A (ja) 神経保護特性を有するピペリジン誘導体
CH664755A5 (de) Aethylendiaminmonoamid-derivat.
JPH0453870B2 (de)
SK94593A3 (en) Farmaceutical agent
CH661043A5 (en) Ethylenediamine monoamide derivatives

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401190-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8401190-7

Format of ref document f/p: F